Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.

por Dorman, D C, Allen, S L, Byczkowski, J Z, Claudio, L, Fisher, J E, Fisher, J W, Harry, G J, Li, A A, Makris, S L, Padilla, S, Sultatos, L G, Mileson, B E
Publicado 2001